RxDoctor Payments Data

Brittany Anderson

Family · Port Huron, MINPI 1982228342

Payments from drug & device makers

$3,256in general payments, 2019–2025

Across 209 payments — averaging $15.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$575
  • Amgen$523
  • UCB, Inc.$486
  • Johnson & Johnson$370
  • E.r. Squibb & Sons, L.L.C.$328
  • Pfizer$156
  • plus $818 from 15 others

What the payments were for

  • Food & beverage$3,23699%
  • Education$201%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,256 in reported general payments places this provider in the 85th percentile of 3,657 family providers in Michigan.

See all family providers in Michigan

Medicare billing

Part B allowed, 2024
$3,523
Medicare patients
66
Services billed
198

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter62$61,863
OzempicSemaglutide36$39,709
JardianceEmpagliflozin18$27,394
EliquisApixaban23$22,087
TrulicityDulaglutide16$21,231
Spiriva HandihalerTiotropium Bromide11$8,482
Albuterol Sulfate HfaAlbuterol Sulfate165$7,881
Fluticasone-SalmeterolFluticasone Propion/Salmeterol18$4,703
Breo ElliptaFluticasone/Vilanterol11$4,134
Lantus SolostarInsulin Glargine,hum.Rec.Anlog31$4,100
Ventolin HfaAlbuterol Sulfate37$2,941
Atorvastatin Calcium267$2,620
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine27$1,787
LantusInsulin Glargine,hum.Rec.Anlog15$1,580
Levothyroxine Sodium139$1,455

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta$104$65,99773 claims
PfizerEliquis$156$22,08723 claims
Lilly USA, LLCTrulicity$84$21,23116 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,657 family providers in Michigan.

Other family in Port Huron

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →